. . . . . "2500141"^^ . "0.95"^^ . "negative" . "3"^^ . . . . . "Sodium-Glucose Cotransporter-2 Inhibitor" . . . "Parkinson Disease" . "Evidence-state label of the citing paper within the GLP-1 pilot corpus (207 papers; supported / contested / single-source / unlabeled), computed from cross-paper agreement over kg.assertions with author-overlap independence exclusions (v2, 2026-09-21)." . . . "supported" . "2026-09-07T05:17:32.123070+00:00"^^ . "universal_pd_v5" . "observational_human" . "SGLT2 inhibitor use was associated with a significantly reduced risk of developing PD (HR = 0.15, 95% CI: 0.10–0.21)." . "2026-11-06T23:32:25+00:00"^^ . . . "Machine-generated by the sciai-lab KG publisher bot (https://pd.sciai.eu/np/bot/sciai-kg-publisher) from the sciai-lab knowledge graph (kg.assertions); not manually authored. Responsible contact: Johannes Keizer (https://orcid.org/0009-0008-6409-2596)." . . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAmbH3DJ0b7gHODI7sDgcVyu5oU1CCZ/ExuejhS0LiNfnjx6SFzKWZDYEvakKaDFZUNkoFzdjVVhBZfV6MKxv3Jh8xzq876JjGkFoNqIO6tUTmMtkpP2eS26/QTPuoAn4psuSIgNCvAk/98cL1wpWS9kl/WNb+1L7RL8mrN72f0P3we555ShsIRgHD8hQJM3cK/naK4JBm350q1nzfUYLhMHUriRlJyXw7JbRnpAAlKCvoIvU4a9X5XM3ULr9ochcIlw7HgZdqD/hrL6CX0c+s0huvKK9SWTkcsO1Xp4oacwUlgPVYFg7OQiyB/WOIV7iXhYlP92s0+KSqX8XJoU2jCQIDAQAB" . "eXOtK6793cwoDDubDGdA08zd3FZjo7l4af5WSBb3PrLMZdP6Pa3RRErt91KOAFQpGUvYONgVofbzi2qQLvW7zvCalcCi0M2OqZYXdhRAhSIuiEeFSEad34FxlLBv6XfcHAzzb2swY2ItZ4ivvI+Q8u2bxzSZUIxoOu0LrRSnw6ThddpvzCNeg6UvFcyG6JxDFsYu2862WGjPLbT6wtgr9P6cnrjczjtKSthxEfeVuY1hBzSk2dlR2iEIZZQBgkWl/FsbBYY4rXuU2r5AklHgIXylbkntFAyr/JEQ1ge9hQoOXVhQacuR9tLHUScVVw80xKvFz3QM1A3B1AbiOchLhw==" . . .